Ricardo Rangel Martinez, B.Sc.

Biologist | Researcher in Regenerative Medicine and Cellular Therapy

Biologist graduated from National Polytechnic Institute (IPN) with more than 25 years of experience in research, development and clinical application of advanced cellular therapies, and immunogenetics and regenerative medicine. His career integrates basic science, technology transfer, biomedical innovation and high-level academic training.

Specialties

Cell therapy and regenerative medicine
Mesenchymal stem cells and secretome
Exosomes and microvesicles with therapeutic application
Immunogenetics and histocompatibility (HLA)
Tissue engineering and bioprinting
Quality control and cell expansion for clinical use

Academic Background

Bachelor's Degree in Biology, National School of Biological Sciences - IPN
Studies of Master's Degree in Chemical-Biological Sciences (40% advance, average 10.0)
Diploma in Regenerative Medicine applied to chronic diseases

Relevant Experience

Vice President, International Society for Exosome-Based Medicine, International Society for Exosome-Based Medicine
CEO, ExomLab - ExomePharma
Director of Research and Teaching in biotechnological institutions
Scientific coordinator of International Congresses on Advanced Therapies
Head of laboratory in immunogenetics, assisted reproduction and cellular banks.
Representative for LATAM of European 3D bioprinting technologies.

Innovation and Intellectual Property

Principal Inventor of patents in skin regeneration and biomedical devices based on exosomes
Development of technologies applied to burns, ophthalmology and advanced regenerative medicine.

Teaching and Scientific Production

Lecturer in international courses and diplomas on stem cells and advanced therapies.
Author and co-author of scientific publications in Human Immunology and other specialized magazines
Participation in projects endorsed by CONACyT and international organizations

Role at Quantum Lab

At Quantum Lab, Biologist Ricardo Rangel Martínez contributes his scientific expertise to the design, validation and monitoring of cellular and biotechnological protocols, ensuring international standards of quality, safety and scientific evidence in each development.